Hamilton Thorne (TSE:HTL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hamilton Thorne Ltd has secured shareholder approval for its ‘going private’ transaction, with over 99.98% support from voting shareholders, excluding certain minority votes. The company, a leader in Assisted Reproductive Technologies (ART), also announced imminent finalization of its acquisition of Cook Medical’s ART portfolio and expected regulatory clearances, anticipating the deal’s closure in Q4 2024. Post-transaction, Hamilton Thorne will be delisted from the TSX and will stop being a reporting issuer in Canada.
For further insights into TSE:HTL stock, check out TipRanks’ Stock Analysis page.